Vivos Therapeutics, Inc. (VVOS)
1.24
-0.06
(-4.62%)
USD |
NASDAQ |
Mar 13, 16:00
1.25
+0.01
(+0.81%)
After-Hours: 20:00
Vivos Therapeutics EPS Diluted (Quarterly) : -0.4925 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Celldex Therapeutics, Inc. | -1.223 |
| Plus Therapeutics, Inc. | -0.0412 |
| Atossa Therapeutics, Inc. | -1.009 |
| Abeona Therapeutics, Inc. | -0.0952 |
| Cell Source, Inc. | -0.021 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.40M |
| Revenue (Quarterly) | 6.783M |
| Total Expenses (Quarterly) | 12.18M |
| Enterprise Value | 20.56M |
| Gross Profit Margin (Quarterly) | 52.38% |
| Profit Margin (Quarterly) | -79.61% |
| Earnings Yield | -159.2% |
| Normalized Earnings Yield | -159.17 |